Manama, July 8 -- The Kingdom of Bahrain is one step closer on using convalescent plasma to treat the COVID-19 infections. Convalescent plasma is antibody-rich products that are collected from eligible donors who have recovered from COVID-19.

Lt. Col. Manaf Al Qahtani, the Infectious Disease Consultant and Microbiologist at the BDF Hospital and member of the National Taskforce for Combating the Coronavirus (COVID-19), said that Bahraini researchers are currently working with the international partners trying to determine its safety and efficacy via clinical trials before routinely administering convalescent plasma to patients with COVID-19.

He was speaking as the National Taskforce for Combating the Coronavirus (COVID-19) held a press c...